Back to Browse Journals » International Journal of Women's Health » Volume 2

Optimal management of nausea and vomiting of pregnancy

Authors Neda Ebrahimi, Caroline Maltepe, Adrienne Einarson

Published Date August 2010 Volume 2010:2 Pages 241—248

DOI http://dx.doi.org/10.2147/IJWH.S6794

Published 4 August 2010

Neda Ebrahimi1,2, Caroline Maltepe2, Adrienne Einarson2

1Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada; 2Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada

Abstract: Nausea and vomiting of pregnancy (NVP) is a common medical condition in pregnancy with significant physical and psychological morbidity. Up to 90% of women will suffer from NVP symptoms in the first trimester of pregnancy with up to 2% developing hyperemesis gravidarum which is NVP at its worst, leading to hospitalization and even death in extreme cases. Optimal management of NVP begins with nonpharmacological approaches, use of ginger, acupressure, vitamin B6, and dietary adjustments. The positive impact of these noninvasive, inexpensive and safe methods has been demonstrated. Pharmacological treatments are available with varying effectiveness; however, the only drug marketed specifically for the treatment of NVP in pregnancy is Diclectin® (vitamin B6 and doxylamine). In addition, the Motherisk algorithm provides a guideline for use of safe and effective drugs for the treatment of NVP. Optimal medical management of symptoms will ensure the mental and physical wellbeing of expecting mothers and their developing babies during this often stressful and difficult time period. Dismissing NVP as an inconsequential part of pregnancy can have serious ramifications for both mother and baby.

Keywords: pharmacological/nonpharmacological treatments, NVP

A Letter to the Editor has been received and published for this article.

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

Taveira-DaSilva AM, Moss J

Clinical Epidemiology 2015, 7:249-257

Published Date: 7 April 2015

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion

Stefanini FR, Maia M, Falabella P, Pfister M, Niemeyer M, Kashani AH, Humayun MS, Koss MJ

Clinical Ophthalmology 2014, 8:847-856

Published Date: 6 May 2014

The Nanomaterial Registry: facilitating the sharing and analysis of data in the diverse nanomaterial community

Ostraat ML, Mills KC, Guzan KA, Murry D

International Journal of Nanomedicine 2013, 8:7-13

Published Date: 16 September 2013

Letter to editor

Reichmann JP

International Journal of Women's Health 2013, 5:35-36

Published Date: 22 January 2013

Amphiphilic graft copolymer based on poly(styrene-co-maleic anhydride) with low molecular weight polyethylenimine for efficient gene delivery

Duan XP, Xiao JS, Yin Q, Zhang ZW, Mao SR, Li YP

International Journal of Nanomedicine 2012, 7:4961-4972

Published Date: 14 September 2012

Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease

Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J

Vascular Health and Risk Management 2012, 8:225-232

Published Date: 17 April 2012

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:247-251

Published Date: 6 July 2011

Tinidazole in the treatment of bacterial vaginosis

Nicola R Armstrong, Janet D Wilson

International Journal of Women's Health 2009, 1:59-65

Published Date: 25 June 2009

Relative safety profiles of high dose statin regimens

Carlos Escobar, Rocio Echarri, Vivencio Barrios

Vascular Health and Risk Management 2008, 4:525-533

Published Date: 30 June 2008